This test has not been reviewed, cleared, or approved by the U. Food and Drug Administration. Excel Pdf. Normal Reports Abnormal Reports.
Test Catalog Test Catalog. Contact Search. Search Cancel. Home Test Catalog Overview. Test Catalog. Order This Test. Useful For Suggests clinical disorders or settings where the test may be helpful. Method Name A short description of the method used to perform the test. Virus Neutralizing Antibody Test. Reporting Name Lists a shorter or abbreviated version of the Published Name for a test. Aliases Lists additional common names for a test, as an aid in searching.
Specimen Type Describes the specimen type validated for testing. Specimen Required Defines the optimal specimen required to perform the test and the preferred volume to complete testing.
Specimen Minimum Volume Defines the amount of sample necessary to provide a clinically relevant result as determined by the Testing Laboratory. Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected. Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the performing laboratory, alternate acceptable temperatures are also included. Clinical Information Discusses physiology, pathophysiology, and general clinical aspects, as they relate to a laboratory test.
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate.
Parainfluenza virus 1, PCR. Parainfluenza virus 2, PCR. Parainfluenza virus 3, PCR. Parainfluenza virus 4, PCR. Human Metapneumovirus, PCR. Human Rhinovirus, PCR. Adenovirus, PCR. Download to Excel. Additional Technical Information. Ordering Recommendation Recommendations when to order or not order the test. May include related or preferred tests.
Mnemonic Unique test identifier. Methodology Process es used to perform the test. Performed Days of the week the test is performed. Specimen Required Patient Preparation. Specimen Preparation. State and local public health departments have required laboratories to report COVID testing results since the beginning of the COVID public health emergency; however, the requirements for patient information and other data elements have varied across states. The new HHS guidance aims to increase the reporting of important data elements, e.
Laboratory data reported to state and jurisdictional health departments will be used to help track the spread of COVID and identify areas that are highly impacted by the disease. The data will also be used to track the spread of disease by location. On a national level, the de-identified data shared with CDC will contribute to understanding national disease incidence and prevalence, case rate positivity trends, and testing coverage, and will help identify supply chain issues for reagents and other materials.
Laboratories are not required to report to both state or local health departments and HHS. The CARES Act requires laboratories to report all data to state or local public health departments using existing public health data reporting channels in accordance with state law or policies. The state health departments will provide these data to HHS. Starting on August 1, , laboratories are expected to make every reasonable effort to report required data elements to the appropriate state or local public health department, as required by HHS guidance.
Ordering providers should make every effort to collect this critical information from patients during the specimen collection process and provide it to the laboratories performing the test. The testing site that performs the COVID test is responsible for reporting to the appropriate state or local public health department.
These more stringent requirements must be followed. Exceptions for the performing reporting requirements might include a hospital system that centralizes data, i. Laboratories need to report test results to the state where the individual is temporarily living or visiting.
Clinicians and laboratories should contact their state or local public health department directly for more information on reporting requirements and the method for reporting. Yes, state or local health departments will still accept these data.
Public health recognizes this information is not always provided in test orders. However, every effort should be made to collect complete data. If test orders are placed electronically, healthcare facilities and laboratories should ensure that the laboratory test order interface can collect or transfer complete demographic data and answers to AOE questions.
Healthcare facilities and laboratories should work with their electronic health record or laboratory information management system vendors to improve the order processes and information exchange between the healthcare provider and the laboratory. If test orders are not placed electronically, submission forms web based or paper should be updated to include the data elements described in the CARES Act Section guidance pdf icon external icon.
Every effort should be made to collect this information because these data are critical for state and local public health departments to plan and execute COVID control and mitigation efforts. These elements should be collected and be conformant with the HL7 Version 2. Yes, all data related to the AOE questions should be collected and reported to state and local public health departments in the electronic laboratory report messages. In general, no.
Laboratories are not responsible for reporting these data. However, local, tribal, or state health department rules and regulations apply and may differ from this general guidance. Laboratories are not responsible for reporting these data since they do not have the patient-identifying information required to comply with reporting requirements.
0コメント